Results 151 to 160 of about 159,226 (361)
The authors conducted a retrospective study of 94 patients with advanced cancer who underwent next‐generation sequencing (NGS) gene panel analysis and received targeted treatments when applicable. Results further support evidence indicating that molecular profiling provides clinical benefit.
Michaël Dang+3 more
wiley +1 more source
Report of Subcommittee D on Recommendations of Referees [PDF]
Margarethe Oakley+2 more
openalex +1 more source
Patient‐derived xenografts (PDXs) can be improved by implantation of a humanized niche. We tested different biomaterials and approaches, and demonstrate that the combination of an injectable biomaterial for scaffold creation plus an intravenous route for acute myeloid leukemia (AML) xenotransplantation provide the most convenient and robust approach to
Daniel Busa+13 more
wiley +1 more source
Acknowledgement to Referees [PDF]
McMillan, Steve, Olney, Roger
openaire +1 more source
Report of Subcommittee C on Recommendations of Referees [PDF]
Reg Chapman, F M Garfield, H Fisghbach
openalex +1 more source
Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer
This study employed targeted metabolomic profiling to identify 302 distinct metabolites present in platelet‐rich plasma (PRP), revealing aberrant metabolic profiles amongst individuals diagnosed with colorectal cancer (CRC). Compared to carcinoembryonic antigen (CEA) and cancer antigen 19‐9 (CA199), our metabolite panel showed improved sensitivity ...
Zuojian Hu+7 more
wiley +1 more source
Towards AI-Powered Video Assistant Referee System (VARS) for Association Football [PDF]
Over the past decade, the technology used by referees in football has improved substantially, enhancing the fairness and accuracy of decisions. This progress has culminated in the implementation of the Video Assistant Referee (VAR), an innovation that enables backstage referees to review incidents on the pitch from multiple points of view. However, the
arxiv
Report of Subcommittee C on Recommendations of Referees [PDF]
Samuel Alfend+2 more
openalex +1 more source
KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells
We demonstrate that decitabine (DEC) not only degrades the DNA methyltransferase DNMT1 but also the leukemic driver lysine methyltransferase KMT2A likely due to structural similarity of the DNA‐binding CXXC domains. DEC influences KMT2A downstream processes and synergizes with menin inhibitor revumenib (REV) to decrease leukemic cell proliferation, and
Luisa Brock+10 more
wiley +1 more source